urea has been researched along with Cardiovascular Stroke in 98 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Landiolol is an ultra-short-acting β-blocker that has less effect on blood pressure, but little is known about its efficacy and safety for patients with AMI undergoing primary percutaneous coronary intervention (PCI)." | 6.77 | Randomized study on the efficacy and safety of landiolol, an ultra-short-acting β1-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. ( Abe, N; Hanada, K; Higuma, T; Kushibiki, M; Nishizaki, F; Oikawa, K; Okumura, K; Osanai, T; Saito, S; Sukekawa, T; Tomita, H; Yamada, M; Yokota, T, 2012) |
| "Landiolol was started intravenously just before reperfusion." | 5.43 | Beneficial effect of early infusion of landiolol, a very short-acting beta-1 adrenergic receptor blocker, on reperfusion status in acute myocardial infarction. ( Doi, H; Endo, T; Ishigami, T; Ishikawa, T; Iwata, K; Kawashima, C; Kimura, K; Kiyokuni, M; Komura, N; Konishi, M; Mitsuhashi, T; Nakayama, N; Narikawa, M; Sakamaki, K; Sugano, T; Tomari, S; Yamanaka, T; Yano, H, 2016) |
| " Serum levels were significantly higher at 8 and 24 hours in those patients who received their first dose intramuscularly compared with those who received their first dose orally, irrespective of the bioavailability of the oral preparation used." | 5.25 | Treatment with digoxin and measurement of serum digoxin levels after myocardial infarction. ( McL White, B; Norris, RM; Sharpe, DN, 1975) |
| "The effects of sulphinpyrazone 800 mg daily on renal excretory function were studied in a double-blind placebo-controlled randomised trial of incremental and full doses of the drug in 28 patients with plasma urea concentration less than 10 mmol/l in the period 2-28 days following uncomplicated acute myocardial infarction." | 5.05 | Sulphinpyrazone and renal function following myocardial infarction. ( Choudhury, SL; Morgan, DB; Swaminathan, R; Taylor, SH; Wieringa, G, 1983) |
| " In this ≥80-year group, history of heart failure, current medication with antiarrhythmic, acute infarction on the arrival electrocardiography, chest x-ray with pleural effusion, and urea greater than 12 mmol/L were independently associated with short-term serious adverse events." | 3.83 | Characteristics and outcomes for acute heart failure in elderly patients presenting to the ED. ( Calder, LA; Claret, PG; Clement, CM; Perry, JJ; Rowe, BH; Stiell, IG; Yan, JW, 2016) |
| " Discriminant function analysis was performed using the following variables: patients' age, history of previous myocardial infarction, diabetes mellitus, blood lactate, urea, creatinine, creatine kinase, aspartate aminotransferase, lactate dehydrogenase concentrations, and chest x-ray cardiothoracic ratio." | 3.68 | Usefulness of blood lactate as a predictor of shock development in acute myocardial infarction. ( Matana, A; Mavrić, Z; Smokvina, D; Zagar, D; Zaputović, L, 1991) |
| "The ability of large doses of exogenous angiotensin II to cause widespread multifocal microscopic myocardial necrosis in the rabbit has been confirmed." | 3.65 | Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man. ( Brown, JJ; Gavras, H; Gray, B; Kremer, D; Lever, AF; MacAdam, RF; medina, A; Morton, JJ; Robertson, JI, 1975) |
| "Plasma urate, urea and creatinine were measured at daily intervals for up to six days in 22 patients suffering from acute myocardial infarction." | 3.65 | Uraemia and hyperuricaemia in acute myocardial infarction. ( Wiener, K, 1976) |
| "Landiolol or saline was administered into target vessels through a balloon catheter for 1min before and after first balloon inflation followed by continuous intravenous administration for 6h after PCI." | 2.78 | Intracoronary followed by intravenous administration of the short-acting β-blocker landiolol prevents myocardial injury in the face of elective percutaneous coronary intervention. ( Iwasaka, J; Iwasaka, T; Noda, T; Okazaki, T; Otani, H; Park, H; Sato, D; Ueyama, T; Yamamoto, Y, 2013) |
| "Landiolol is an ultra-short-acting β-blocker that has less effect on blood pressure, but little is known about its efficacy and safety for patients with AMI undergoing primary percutaneous coronary intervention (PCI)." | 2.77 | Randomized study on the efficacy and safety of landiolol, an ultra-short-acting β1-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. ( Abe, N; Hanada, K; Higuma, T; Kushibiki, M; Nishizaki, F; Oikawa, K; Okumura, K; Osanai, T; Saito, S; Sukekawa, T; Tomita, H; Yamada, M; Yokota, T, 2012) |
| "Landiolol is an intravenous, selective beta-1-receptor blocking agent with rapid onset of action and ultra-short half-life that has a predominant negative chronotropic and only mild negative inotropic effect without significant reduction of blood pressure." | 1.72 | The application of landiolol in the cardiovascular and intensive care ( Fejér, C; Gellér, L; Kiss, B; Kovács, E; Merkely, B; Pilecky, D; Radics, P; Ruzsa, Z; Straub, É; Zima, E, 2022) |
| "The incidence of arrhythmias was assessed by in vivo electrophysiologic studies." | 1.48 | Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction. ( Chen, J; Deng, L; Du, X; Gui, Y; Hu, J; Li, D; Liao, C; Wang, Y; Xiang, Q; Xu, D; Yang, T; Zhang, S, 2018) |
| "Landiolol was started intravenously just before reperfusion." | 1.43 | Beneficial effect of early infusion of landiolol, a very short-acting beta-1 adrenergic receptor blocker, on reperfusion status in acute myocardial infarction. ( Doi, H; Endo, T; Ishigami, T; Ishikawa, T; Iwata, K; Kawashima, C; Kimura, K; Kiyokuni, M; Komura, N; Konishi, M; Mitsuhashi, T; Nakayama, N; Narikawa, M; Sakamaki, K; Sugano, T; Tomari, S; Yamanaka, T; Yano, H, 2016) |
| "Omecamtiv mecarbil (OM) is a novel inotropic agent that prolongs systolic ejection time and increases ejection fraction through myosin ATPase activation." | 1.42 | Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Resting Myosin ATPase Activity. ( Aasum, E; Bakkehaug, JP; Boardman, N; Engstad, ET; How, OJ; Kildal, AB; Larsen, TS; Myrmel, T; Næsheim, T; Rønning, L, 2015) |
| "Uremia was induced by partial nephrectomy in male Wistar rats." | 1.38 | Preconditioning protects the heart in a prolonged uremic condition. ( Bencsik, P; Csonka, C; Csont, T; Ferdinandy, P; Kocsis, GF; Pálóczi, J; Pipicz, M; Sárközy, M; Varga, ZV, 2012) |
| " Dosing of diuretics is difficult in these patients." | 1.37 | Management of diuretic treatment: a challenge in the obese patient. ( Jespersen, B; Lassen, CK, 2011) |
| "Inducibility of ventricular arrhythmias was examined by programmed stimulation." | 1.31 | Salutary antiarrhythmic effect of combining a K channel blocker and a beta-blocker in a canine model of 7-day-old myocardial infarction. ( Kanki, H; Mitamura, H; Ogawa, S; Sueyoshi, K; Takatsuki, S, 2000) |
| " Serum levels were significantly higher at 8 and 24 hours in those patients who received their first dose intramuscularly compared with those who received their first dose orally, irrespective of the bioavailability of the oral preparation used." | 1.25 | Treatment with digoxin and measurement of serum digoxin levels after myocardial infarction. ( McL White, B; Norris, RM; Sharpe, DN, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 63 (64.29) | 18.7374 |
| 1990's | 2 (2.04) | 18.2507 |
| 2000's | 8 (8.16) | 29.6817 |
| 2010's | 24 (24.49) | 24.3611 |
| 2020's | 1 (1.02) | 2.80 |
| Authors | Studies |
|---|---|
| Radics, P | 1 |
| Kiss, B | 1 |
| Kovács, E | 1 |
| Pilecky, D | 1 |
| Ruzsa, Z | 1 |
| Straub, É | 1 |
| Fejér, C | 1 |
| Gellér, L | 1 |
| Merkely, B | 1 |
| Zima, E | 1 |
| Lüscher, TF | 1 |
| Li, R | 1 |
| Tang, X | 1 |
| Jing, Q | 1 |
| Wang, Q | 1 |
| Yang, M | 1 |
| Han, X | 1 |
| Zhao, J | 1 |
| Yu, X | 1 |
| Fuetterer, M | 1 |
| Busch, J | 1 |
| Peereboom, SM | 1 |
| von Deuster, C | 1 |
| Wissmann, L | 1 |
| Lipiski, M | 1 |
| Fleischmann, T | 1 |
| Cesarovic, N | 1 |
| Stoeck, CT | 1 |
| Kozerke, S | 1 |
| Gui, Y | 1 |
| Li, D | 1 |
| Chen, J | 1 |
| Wang, Y | 1 |
| Hu, J | 1 |
| Liao, C | 1 |
| Deng, L | 1 |
| Xiang, Q | 1 |
| Yang, T | 1 |
| Du, X | 1 |
| Zhang, S | 1 |
| Xu, D | 1 |
| Furuichi, Y | 1 |
| Sakamoto, A | 1 |
| Bakkehaug, JP | 2 |
| Kildal, AB | 2 |
| Engstad, ET | 2 |
| Boardman, N | 2 |
| Næsheim, T | 2 |
| Rønning, L | 2 |
| Aasum, E | 2 |
| Larsen, TS | 2 |
| Myrmel, T | 2 |
| How, OJ | 2 |
| Kanamori, K | 1 |
| Aoyagi, T | 1 |
| Mikamo, T | 1 |
| Tsutsui, K | 1 |
| Kunishima, T | 1 |
| Inaba, H | 1 |
| Hayami, N | 1 |
| Murakawa, Y | 1 |
| Teerlink, JR | 1 |
| Malik, FI | 2 |
| Kass, DA | 1 |
| Kiyokuni, M | 1 |
| Konishi, M | 1 |
| Sakamaki, K | 1 |
| Kawashima, C | 1 |
| Narikawa, M | 1 |
| Doi, H | 1 |
| Iwata, K | 1 |
| Tomari, S | 1 |
| Nakayama, N | 1 |
| Komura, N | 1 |
| Mitsuhashi, T | 1 |
| Yano, H | 1 |
| Sugano, T | 1 |
| Ishigami, T | 1 |
| Endo, T | 1 |
| Ishikawa, T | 1 |
| Yamanaka, T | 1 |
| Kimura, K | 1 |
| Claret, PG | 1 |
| Stiell, IG | 1 |
| Yan, JW | 1 |
| Clement, CM | 1 |
| Rowe, BH | 1 |
| Calder, LA | 1 |
| Perry, JJ | 1 |
| Gevorgyan, MM | 1 |
| Voronina, NP | 1 |
| Goncharova, NV | 1 |
| Kozaruk, TV | 1 |
| Russkikh, GS | 1 |
| Bogdanova, LA | 1 |
| Korolenko, TA | 1 |
| Motoki, A | 1 |
| Merkel, MJ | 1 |
| Packwood, WH | 1 |
| Cao, Z | 1 |
| Liu, L | 1 |
| Iliff, J | 1 |
| Alkayed, NJ | 1 |
| Van Winkle, DM | 1 |
| Gross, GJ | 1 |
| Nithipatikom, K | 1 |
| Park, H | 2 |
| Otani, H | 2 |
| Oishi, C | 1 |
| Fujikawa, M | 1 |
| Yamashita, K | 1 |
| Okazaki, T | 2 |
| Sato, D | 2 |
| Ueyama, T | 2 |
| Iwasaka, J | 2 |
| Yamamoto, Y | 2 |
| Iwasaka, T | 2 |
| Li, N | 2 |
| Liu, JY | 1 |
| Timofeyev, V | 1 |
| Qiu, H | 1 |
| Hwang, SH | 3 |
| Tuteja, D | 1 |
| Lu, L | 1 |
| Yang, J | 1 |
| Mochida, H | 1 |
| Low, R | 1 |
| Hammock, BD | 4 |
| Chiamvimonvat, N | 2 |
| Chaudhary, KR | 1 |
| Abukhashim, M | 1 |
| Seubert, JM | 1 |
| Shen, YT | 1 |
| Zhao, X | 1 |
| Depre, C | 1 |
| Dhar, SK | 1 |
| Abarzúa, P | 1 |
| Morgans, DJ | 1 |
| Vatner, SF | 1 |
| Eran, O | 1 |
| Novack, V | 1 |
| Gilutz, H | 1 |
| Zahger, D | 1 |
| Lassen, CK | 1 |
| Jespersen, B | 1 |
| Hanada, K | 1 |
| Higuma, T | 1 |
| Nishizaki, F | 1 |
| Sukekawa, T | 1 |
| Yokota, T | 1 |
| Yamada, M | 1 |
| Saito, S | 1 |
| Kushibiki, M | 1 |
| Oikawa, K | 1 |
| Abe, N | 1 |
| Tomita, H | 1 |
| Osanai, T | 1 |
| Okumura, K | 1 |
| Yoshiyama, M | 1 |
| Neckář, J | 1 |
| Kopkan, L | 1 |
| Husková, Z | 1 |
| Kolář, F | 1 |
| Papoušek, F | 1 |
| Kramer, HJ | 1 |
| Imig, JD | 1 |
| Malý, J | 1 |
| Netuka, I | 1 |
| Ošťádal, B | 1 |
| Červenka, L | 1 |
| Xu, DY | 1 |
| Davis, BB | 1 |
| Wang, ZH | 1 |
| Zhao, SP | 1 |
| Wasti, B | 1 |
| Liu, ZL | 1 |
| Morisseau, C | 1 |
| Yoshitake, I | 1 |
| Hata, M | 1 |
| Sezai, A | 1 |
| Unosawa, S | 1 |
| Wakui, S | 1 |
| Kimura, H | 1 |
| Nakata, K | 1 |
| Hata, H | 1 |
| Shiono, M | 1 |
| Noda, T | 1 |
| Kocsis, GF | 1 |
| Sárközy, M | 1 |
| Bencsik, P | 1 |
| Pipicz, M | 1 |
| Varga, ZV | 1 |
| Pálóczi, J | 1 |
| Csonka, C | 1 |
| Ferdinandy, P | 1 |
| Csont, T | 1 |
| SEMPLE, T | 1 |
| DALL, JL | 1 |
| LANCASTER, WM | 1 |
| WANG, I | 1 |
| GRIGOR, K | 1 |
| PEEL, AA | 1 |
| MCKECHNIE, JK | 1 |
| DAVIDSON, FJ | 1 |
| KEDRA, M | 1 |
| POLESZAK, J | 1 |
| TARKOWSKA, A | 1 |
| HOFFMANN, RG | 1 |
| WAID, ME | 1 |
| ZOLI, A | 1 |
| BRAT, A | 1 |
| GIARDINA, A | 1 |
| JACOBSON, YG | 1 |
| MUNDTH, E | 1 |
| DEFALCO, A | 1 |
| BRETTSCHNEIDER, L | 1 |
| MCCLENATHAN, E | 1 |
| JOCHWEDS, B | 1 |
| Ebel, D | 1 |
| Redler, S | 1 |
| Preckel, B | 1 |
| Schlack, W | 1 |
| Thämer, V | 1 |
| Goyagi, T | 1 |
| Kimura, T | 1 |
| Nishikawa, T | 1 |
| Tobe, Y | 1 |
| Masaki, Y | 1 |
| D'iachenko, TC | 1 |
| Verovckiĭ, VE | 1 |
| Ostrovskiĭ, OV | 1 |
| Iakovlev, AT | 1 |
| Lopatin, IuM | 1 |
| Benko, T | 1 |
| Fehérvári, I | 1 |
| Rácz, K | 1 |
| Friedrich, O | 1 |
| Gálfy, I | 1 |
| Török, S | 1 |
| Remport, A | 1 |
| Járay, J | 1 |
| Bodor, E | 1 |
| Szabolcs, Z | 1 |
| Lindy, S | 4 |
| Konttinen, A | 5 |
| Choudhury, SL | 1 |
| Taylor, SH | 1 |
| Wieringa, G | 1 |
| Swaminathan, R | 1 |
| Morgan, DB | 1 |
| Wilcox, RG | 1 |
| Richardson, D | 1 |
| Hampton, JR | 1 |
| Mitchell, JR | 1 |
| Banks, DC | 1 |
| Moseley, MJ | 1 |
| Sawminathan, R | 1 |
| Morgan, B | 1 |
| Aleksandrov, VN | 1 |
| Markin, SA | 1 |
| Shastin, IV | 1 |
| Antipov, AB | 1 |
| Pozin, AI | 1 |
| Gillespy, WG | 1 |
| Karlsen, RL | 1 |
| Nørgaard, L | 1 |
| Guldbrandsen, EB | 1 |
| Evans, AE | 1 |
| Boyle, DM | 1 |
| Barber, JM | 1 |
| McIlmoyle, EL | 1 |
| Walsh, MJ | 1 |
| Chaturvedi, NC | 1 |
| Mackenzie, G | 1 |
| Elwood, JH | 1 |
| Takatsuki, S | 1 |
| Mitamura, H | 1 |
| Kanki, H | 1 |
| Sueyoshi, K | 1 |
| Ogawa, S | 1 |
| Barnes, AJ | 1 |
| Locke, P | 1 |
| Scudder, PR | 1 |
| Dormandy, TL | 1 |
| Dormandy, JA | 1 |
| Slack, J | 1 |
| Bulpitt, CJ | 2 |
| Beilin, LJ | 1 |
| Clifton, P | 1 |
| Coles, EC | 2 |
| Dollery, CT | 1 |
| Gear, JS | 1 |
| Harper, GS | 1 |
| Johnson, BF | 1 |
| Munro-Faure, AD | 2 |
| Denis, B | 1 |
| Machecourt, J | 1 |
| Denis, MC | 1 |
| Morena, H | 1 |
| Pellet, J | 1 |
| Rossignol, B | 1 |
| Martin-Noël, P | 1 |
| Cherpachenko, NM | 2 |
| Gavras, H | 2 |
| Kremer, D | 1 |
| Brown, JJ | 2 |
| Gray, B | 1 |
| Lever, AF | 2 |
| MacAdam, RF | 2 |
| medina, A | 1 |
| Morton, JJ | 1 |
| Robertson, JI | 2 |
| Schjøth, AE | 1 |
| Brandt, E | 1 |
| Ditlefsen, EM | 1 |
| Weiner, K | 1 |
| Fetisova, TV | 3 |
| Wiener, K | 3 |
| Smith, AH | 1 |
| Simpson, FO | 1 |
| Sharpe, DN | 1 |
| Norris, RM | 1 |
| McL White, B | 1 |
| Mavrić, Z | 1 |
| Zaputović, L | 1 |
| Zagar, D | 1 |
| Matana, A | 1 |
| Smokvina, D | 1 |
| Marik, PE | 1 |
| Lipman, J | 1 |
| Eidelman, IJ | 1 |
| Erskine, PJ | 1 |
| Pisarenko, OI | 1 |
| Studneva, IM | 1 |
| Woo, KS | 1 |
| Zoloev, GK | 1 |
| Slepushkin, VD | 1 |
| Vasil'tsev, IaS | 1 |
| Titov, MI | 1 |
| Beevers, DG | 2 |
| Butler, A | 1 |
| Hunt, D | 1 |
| Newson, RB | 1 |
| O'Riordan, PW | 1 |
| Petrie, JC | 1 |
| Rajagopalan, B | 1 |
| Fairman, MJ | 1 |
| Hamilton, M | 1 |
| Harpur, JE | 1 |
| Shaw, TR | 1 |
| Kumana, CR | 1 |
| Royds, RB | 1 |
| Padgham, CM | 1 |
| Hamer, J | 1 |
| Menon, IS | 1 |
| Dewar, HA | 1 |
| Wilcken, DE | 1 |
| Lvoff, R | 1 |
| Zabolotniuk, IP | 1 |
| Discombe, G | 1 |
| Lund, S | 1 |
| Brydon, WG | 1 |
| Smith, AF | 1 |
| Genest, J | 1 |
| Boucher, R | 1 |
| Kuchel, O | 1 |
| Nowaczynski, W | 1 |
| Smetnev, AS | 1 |
| Petrova, LI | 1 |
| Zakin, AM | 1 |
| Smirnov, VN | 2 |
| Asafov, GB | 2 |
| Chernousova, GB | 1 |
| Mozzhechkov, VT | 1 |
| Krivov, VI | 1 |
| Ovchinnikov, IA | 1 |
| Merimson, VG | 1 |
| Rozynov, VG | 1 |
| Chumachenko, MN | 1 |
| Chapman, BL | 1 |
| Gray, CH | 1 |
| Serrera Contreras, JL | 1 |
| Rey Romero, C | 1 |
| Pedrote Guinea, JA | 1 |
| Sharma, AK | 1 |
| Datta, P | 1 |
| Chazov, E | 1 |
| Mazaev, AV | 1 |
| Gukowski, DU | 1 |
| Krikov, VI | 1 |
| Hanson, NQ | 1 |
| Freier, EF | 1 |
| Auvinen, S | 1 |
| Lennon, PA | 1 |
| Adam, WR | 1 |
| Bladin, P | 1 |
| Coote, BD | 1 |
| Dawborn, JK | 1 |
| Greer, CH | 1 |
| Sliwińska, J | 1 |
| Kolber-Postepska, B | 1 |
| Chopra, MP | 1 |
| Gulati, RB | 1 |
| Portal, RW | 1 |
| Aber, CP | 1 |
| Koine, A | 1 |
| Nagel, R | 1 |
| Keysser, M | 1 |
| Donath, R | 1 |
| Sinha, R | 1 |
| Trew, JA | 1 |
| Zysko, AP | 1 |
| Ruda, MIa | 1 |
| Lubran, M | 1 |
| Jensen, WE | 1 |
| Ignatowska-Switalska, H | 1 |
| Stach, L | 1 |
| Bar-Andziak, E | 1 |
| Bohn, L | 1 |
| Bendixen, G | 1 |
| Hjermind, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Role of Innate and Adaptive Immunity After Acute Myocardial Infarction BATTLE-AMI Study (B And T Types of Lymphocytes Evaluation in Acute Myocardial Infarction)[NCT02428374] | Phase 4 | 300 participants (Anticipated) | Interventional | 2015-05-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for urea and Cardiovascular Stroke
| Article | Year |
|---|---|
[Perioperative cardiovascular evaluation and management for noncardiac surgery].
Topics: Adrenergic beta-Antagonists; Anesthesia; Atenolol; Bisoprolol; Fatty Acids, Monounsaturated; Fluvast | 2014 |
Soluble epoxide hydrolase: a new target for cardioprotection.
Topics: Adamantane; Animals; Cardiomegaly; Cardiotonic Agents; Coronary Disease; Dose-Response Relationship, | 2009 |
[The first successful combined heart-kidney transplantation in Hungary].
Topics: Adult; Biomarkers; Cardiomyopathy, Dilated; Creatinine; Critical Care; Heart Transplantation; Hemodi | 2008 |
5 trials available for urea and Cardiovascular Stroke
| Article | Year |
|---|---|
The effect of trimetazidine treatment in patients with type 2 diabetes undergoing percutaneous coronary intervention for AMI.
Topics: Adenosine; Aged; Alanine Transaminase; Aspartate Aminotransferases; Aspirin; Blood Glucose; Cardiac | 2017 |
Randomized study on the efficacy and safety of landiolol, an ultra-short-acting β1-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Topics: Adrenergic beta-1 Receptor Antagonists; Angioplasty, Balloon, Coronary; Combined Modality Therapy; F | 2012 |
Intracoronary followed by intravenous administration of the short-acting β-blocker landiolol prevents myocardial injury in the face of elective percutaneous coronary intervention.
Topics: Adrenergic beta-Antagonists; Aged; Elective Surgical Procedures; Female; Humans; Infusions, Intra-Ar | 2013 |
Sulphinpyrazone and renal function following myocardial infarction.
Topics: Adult; Aged; Creatinine; Double-Blind Method; Female; Humans; Kidney; Male; Middle Aged; Myocardial | 1983 |
Sulphinpyrazone in acute myocardial infarction: studies on cardiac rhythm and renal function.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Creatinine; Double-Blind Method; Female; Humans; Mal | 1980 |
90 other studies available for urea and Cardiovascular Stroke
| Article | Year |
|---|---|
The application of landiolol in the cardiovascular and intensive care
Topics: Atrial Fibrillation; Critical Care; Heart Rate; Humans; Morpholines; Myocardial Infarction; Urea | 2022 |
Optimizing heart failure management: anticoagulation, diuretic withdrawal, iron substitution, and novel inotropes.
Topics: Acute Disease; Anemia, Iron-Deficiency; Anticoagulants; Cardiotonic Agents; Case-Control Studies; Di | 2019 |
Hyperpolarized
Topics: Animals; Blood Flow Velocity; Carbon Isotopes; Contrast Media; Coronary Circulation; Disease Models, | 2017 |
Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Benzoates; Disease Models, Animal; Down-Regulation; ERG1 Potassium Ch | 2018 |
Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Resting Myosin ATPase Activity.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Energy Metabo | 2015 |
Successful Treatment of Refractory Electrical Storm With Landiolol After More Than 100 Electrical Defibrillations.
Topics: Adrenergic beta-Antagonists; Aged, 80 and over; Coronary Angiography; Electric Countershock; Electro | 2015 |
Letter by Teerlink et al Regarding Article, "Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Resting Myosin ATPase Activity".
Topics: Animals; Cardiotonic Agents; Enzyme Activators; Female; Heart Failure; Male; Myocardial Infarction; | 2015 |
Response to Letter Regarding Article, "Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Resting Myosin ATPase Activity".
Topics: Animals; Cardiotonic Agents; Enzyme Activators; Female; Heart Failure; Male; Myocardial Infarction; | 2015 |
Beneficial effect of early infusion of landiolol, a very short-acting beta-1 adrenergic receptor blocker, on reperfusion status in acute myocardial infarction.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Female; Humans; Infusions, Intravenous; Male; Middle A | 2016 |
Characteristics and outcomes for acute heart failure in elderly patients presenting to the ED.
Topics: Acute Disease; Age Factors; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Blood Pressure; Electro | 2016 |
Cystatin C as a Marker of Progressing Cardiovascular Events during Coronary Heart Disease.
Topics: Aged; Biomarkers; C-Reactive Protein; Case-Control Studies; Coronary Disease; Creatinine; Cystatin C | 2017 |
Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
Topics: 8,11,14-Eicosatrienoic Acid; Adamantane; Animals; Disease Models, Animal; Enzyme Inhibitors; Epoxide | 2008 |
Efficacy of intracoronary administration of a short-acting β-blocker landiolol during reperfusion in pigs.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Vessels; Dose-Response Relationship, Drug; Injections | 2011 |
Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches.
Topics: Animals; Apoptosis; Arrhythmias, Cardiac; Benzoates; Chromatography, Liquid; Cytokines; Disease Mode | 2009 |
Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury.
Topics: Animals; Arachidonic Acid; Benzoates; Dose-Response Relationship, Drug; Eicosanoids; Epoxide Hydrola | 2010 |
Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure.
Topics: Analysis of Variance; Animals; Cardiac Myosins; Consciousness; Disease Models, Animal; Dobutamine; D | 2010 |
Comparison of thrombolysis in myocardial infarction, Global Registry of Acute Coronary Events, and Acute Physiology and Chronic Health Evaluation II risk scores in patients with acute myocardial infarction who require mechanical ventilation for more than
Topics: Aged; APACHE; Cardiac Care Facilities; Female; Glomerular Filtration Rate; Health Status Indicators; | 2011 |
Management of diuretic treatment: a challenge in the obese patient.
Topics: Acute Kidney Injury; Aged; Biomarkers; Comorbidity; Creatinine; Diuretics; Drug Overdose; Furosemide | 2011 |
Effect and safety of landiolol in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Female; Humans; Male; Morpholines; Myocardial Infarction; Urea; Vent | 2012 |
Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Benzoates; Blood Pressure; C | 2012 |
A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction.
Topics: Aged; Anilides; Benzoates; Cells, Cultured; Endothelial Cells; Enzyme Inhibitors; Epoxide Hydrolases | 2013 |
The effect of combined treatment with Impella(®) and landiolol in a swine model of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Combined Modality Therapy; Disease Models, Animal; Heart; Hear | 2012 |
Preconditioning protects the heart in a prolonged uremic condition.
Topics: Angiotensin II; Animals; Biomarkers; Creatinine; Disease Models, Animal; Ischemic Preconditioning, M | 2012 |
THE MANAGEMENT OF MEDICAL CARDIAC ARREST.
Topics: Aortic Valve Stenosis; Bicarbonates; Coronary Disease; Diuretics; Electrocardiography; Epinephrine; | 1963 |
CORONARY ARTERY DISEASE IN NATAL INDIANS.
Topics: Aspartate Aminotransferases; Blood Chemical Analysis; Blood Pressure Determination; Cholesterol; Cor | 1964 |
[RENAL FUNCTION IN MYOCARDIAL INFARCT].
Topics: Creatine; Creatinine; Humans; Kidney Function Tests; Myocardial Infarction; Urea | 1963 |
A NEW SCALE OF NORMAL VALUES FOR PHYSICIANS.
Topics: Blood; Blood Chemical Analysis; Clinical Enzyme Tests; Clinical Laboratory Techniques; Glomeruloneph | 1964 |
[METABOLIC EFFECTS OF PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE IN HEALTHY PERSONS AND IN PATIENTS WITH ISCHEMIC HEART DISEASES. 3. CRITICAL EXAMINATION OF THE RESULTS AND CONCLUSIVE CONSIDERATIONS].
Topics: Biphenyl Compounds; Blood Pressure; Catecholamines; Cholesterol; Heart Failure; Metabolism; Myocardi | 1963 |
AN EXPERIMENTAL STUDY OF THE METABOLIC AND PHYSIOLOGIC CHANGES OCCURRING DURING PARTIAL LEFT HEART BYPASS.
Topics: Acid-Base Equilibrium; Blood Platelets; Blood Urea Nitrogen; Calcium; Chlorides; Creatine; Creatinin | 1965 |
[Observations on various forms of azotemia in the course of myocardial infarct].
Topics: Azotemia; Blood Urea Nitrogen; Humans; Myocardial Infarction; Urea | 1960 |
Moderate glucose deprivation preconditions myocardium against infarction.
Topics: Animals; Glucose; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myoc | 2005 |
Beta-adrenoreceptor antagonists attenuate brain injury after transient focal ischemia in rats.
Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics, Inhalation; Animals; Brain; Carbazoles; Carved | 2006 |
[Informative value of plasma biochemical parameters in acute and chronic coronary heart disease].
Topics: Acute Disease; Aged; Angina Pectoris; Bilirubin; Blood Chemical Analysis; Blood Glucose; Blood Prote | 2007 |
Urea-stable lactate dehydrogenase as an index of cardiac isoenzymes.
Topics: Anemia, Pernicious; Clinical Enzyme Tests; Coronary Disease; Humans; Isoenzymes; L-Lactate Dehydroge | 1967 |
Assay of cardiac lactate dehydrogenase iso-enzymes by means of urea.
Topics: Coronary Disease; Electrocardiography; Electrophoresis; Humans; Isoenzymes; L-Lactate Dehydrogenase; | 1967 |
Lactate dehydrogenase activity in high pyruvate concentrations modified by urea.
Topics: Clinical Enzyme Tests; Hepatitis A; Humans; In Vitro Techniques; Isoenzymes; L-Lactate Dehydrogenase | 1967 |
Raised plasma urea levels after myocardial infarction.
Topics: Aged; Creatinine; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Myocardial Infarcti | 1981 |
[Changes in the osmotic state of blood in acute myocardial infarct].
Topics: Aged; Blood Glucose; Blood Volume; Humans; Middle Aged; Myocardial Infarction; Osmolar Concentration | 1980 |
Raised plasma urea levels after myocardial infarction. Errors.
Topics: Humans; Myocardial Infarction; Urea | 1981 |
A rapid method for the determination of urea stable lactate dehydrogenase on the 'Cobas Bio' centrifugal analyser.
Topics: Centrifugation; Drug Stability; Humans; Kinetics; L-Lactate Dehydrogenase; Liver; Liver Diseases; My | 1981 |
Safe selection of coronary patients for early discharge.
Topics: Age Factors; Aged; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Male; Myocardial Infar | 1981 |
Salutary antiarrhythmic effect of combining a K channel blocker and a beta-blocker in a canine model of 7-day-old myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, | 2000 |
Is hyperviscosity a treatable component of diabetic microcirculatory disease?
Topics: Adult; Aged; Aneurysm; Blood Glucose; Blood Proteins; Blood Viscosity; Capillaries; Creatinine; Diab | 1977 |
Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. Hypertension Care Computing Project.
Topics: Age Factors; Aged; Blood Pressure; England; Female; Follow-Up Studies; Humans; Hypertension; Kidney; | 1979 |
[Value of potassium canrenoate in the prevention of arrhythmia during the acute phase of myocardial infarction].
Topics: Acute Disease; Aged; Arrhythmias, Cardiac; Canrenoic Acid; Creatinine; Electrolytes; Female; Humans; | 1979 |
[Histochemical data on changes of various indicators of protein metabolism in the myocardium beyond the infarct zone].
Topics: Adenosine Triphosphatases; Animals; DNA; Glutamate Dehydrogenase; Glutamates; Histocytochemistry; Le | 1978 |
Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man.
Topics: Acute Kidney Injury; Adult; Angiotensin II; Animals; Cephaloridine; Female; Heart Diseases; Humans; | 1975 |
[Urea-stable lactate dehydrogenase. Diagnostic value in myocardial infarction].
Topics: Clinical Enzyme Tests; Creatine Kinase; Humans; Isoenzymes; L-Lactate Dehydrogenase; Myocardial Infa | 1979 |
Raised plasma urea concentration.
Topics: Creatinine; Heart Failure; Humans; Myocardial Infarction; Urea | 1977 |
Protein and polynucleotide metabolism in skeletal muscles in dogs with experimental myocardial infarction.
Topics: Actomyosin; Adenosine Monophosphate; Alanine Transaminase; Amino Acids; Aminohydrolases; Ammonia; An | 1978 |
Plasma calcium in acute myocardial infarction.
Topics: Calcium; Humans; Myocardial Infarction; Phosphates; Serum Albumin; Time Factors; Urea | 1977 |
Plasma cortisol, corticosterone and urea in acute myocardial infarction: clinical and biochemical correlations.
Topics: Acute Disease; Aged; Aspartate Aminotransferases; Corticosterone; Female; Humans; Hydrocortisone; Ma | 1977 |
Uraemia and hyperuricaemia in acute myocardial infarction.
Topics: Acute Disease; Creatinine; Humans; Male; Myocardial Infarction; Urea; Uremia; Uric Acid | 1976 |
Discriminant function analysis of factors related to myocardial infarction in male patients on antihypertensive therapy.
Topics: Age Factors; Blood Pressure; Body Weight; Cholesterol; Humans; Hypertension; Male; Middle Aged; Myoc | 1976 |
[Certain nitrogen-containing components of the heart, of the coronary-sinus blood and of the aorta in experimental myocardial infarct].
Topics: Ammonia; Animals; Aorta; Arginase; Coronary Vessels; DNA; Dogs; Glutamine; Myocardial Infarction; My | 1976 |
Treatment with digoxin and measurement of serum digoxin levels after myocardial infarction.
Topics: Administration, Oral; Arrhythmias, Cardiac; Creatinine; Digoxin; Heart Arrest; Humans; Injections, I | 1975 |
Usefulness of blood lactate as a predictor of shock development in acute myocardial infarction.
Topics: Humans; Lactates; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Sensitivity and Spe | 1991 |
Clinical predictors of early death in acute myocardial infarction. A prospective study of 233 patients.
Topics: Age Factors; Coronary Care Units; Electrocardiography; Humans; Myocardial Infarction; Patient Admiss | 1990 |
[Mechanisms of ammonia binding in the heart muscle].
Topics: Alanine; Amino Acids; Ammonia; Animals; Aspartic Acid; Glutamates; Glutamic Acid; Glutamine; In Vitr | 1985 |
Coronary prognostic index for the Chinese.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Blood Pressure; China; Female; Hu | 1987 |
[Effect of the synthetic enkephalin dalargin on metabolic indices in myocardial infarct patients].
Topics: Adult; Aged; Blood Glucose; Calcium; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Humans; Lac | 1987 |
The survival of treated hypertensive patients and their causes of death: a report from the DHSS hypertensive care computing project (DHCCP).
Topics: Adolescent; Adult; Aged; Blood Glucose; Cerebrovascular Disorders; Coronary Disease; England; Female | 1986 |
Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Bicarbonates; Body Weight; Creatinine; Diagnosis, Diff | 1971 |
Antihypertensive treatment and the course of established cerebral vascular disease.
Topics: Angina Pectoris; Antihypertensive Agents; Cardiomegaly; Cerebrovascular Disorders; Diuretics; Female | 1973 |
Use of plasma levels in evaluation of procainamide dosage.
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Body Weight; Cardiac Complexes, Premature; | 1974 |
Increased blood-urea during phenformin therapy.
Topics: Adult; Female; Fibrinolytic Agents; Humans; Male; Metformin; Middle Aged; Myocardial Infarction; Phe | 1970 |
Glucagon in resistant heart-failure and cardiogenic shock.
Topics: Adult; Bundle-Branch Block; Cardiac Glycosides; Cardiac Output; Cardiomegaly; Diuretics; Electrolyte | 1970 |
[Effect of glucose and insulin in tissue proteins in experimental myocardial infarct].
Topics: Adenosine Triphosphatases; Animals; Arginase; Aspartate Aminotransferases; Dogs; Glucose; Glutaminas | 1969 |
Clinical applicability of urea-LDH test in various pyruvate concentrations.
Topics: Anemia, Hemolytic; Anemia, Pernicious; Clinical Enzyme Tests; Diagnosis, Differential; Humans; Isoen | 1967 |
Urea inhibition of lactate dehydrogenase. A convenient routine procedure.
Topics: Anemia; Buffers; Clinical Enzyme Tests; Glycine; Humans; Ischemia; L-Lactate Dehydrogenase; Liver; L | 1970 |
An appraisal of routine methods for the determination of the anodal isoenzymes of lactate dehydrogenase.
Topics: Adult; Drug Stability; Electrophoresis; Hot Temperature; Humans; Hydroxybutyrate Dehydrogenase; Indi | 1973 |
Renin in hypertension: how important as a risk factor?
Topics: Adult; Angiotensin II; Aortic Aneurysm; Aortic Rupture; Blood Pressure; Cerebrovascular Disorders; C | 1973 |
[Treating pulmonary edema in patients with myocardial infarct].
Topics: Cardiac Glycosides; Diuretics; Ganglionic Blockers; Heparin; Humans; Myocardial Infarction; Neurolep | 1971 |
Ammonia neutralization and urea synthesis in cardiac muscle.
Topics: Adult; Ammonia; Animals; Arginase; Arginine; Cardiac Catheterization; Coronary Disease; Coronary Ves | 1974 |
Prognostic index for myocardial infarction treated in a coronary care unit.
Topics: Anuria; Aspartate Aminotransferases; Blood Glucose; Cholesterol; Coronary Care Units; Electrocardiog | 1973 |
[Biochemical development of myocardial infarct].
Topics: Blood Cell Count; Blood Glucose; Electrophoresis; Hematocrit; Humans; Myocardial Infarction; Time Fa | 1973 |
Comparative evaluation of two simple methods of estimation of serum lactic dehydrogenase in the diagnosis of myocardial infarction.
Topics: Adult; Aged; Clinical Enzyme Tests; Female; Hot Temperature; Humans; Isoenzymes; L-Lactate Dehydroge | 1973 |
Myocardial ammonia metabolism in patients with heart disease as revealed by coronary sinus catheterization study.
Topics: Adult; Alanine; Ammonia; Cardiac Catheterization; Cineangiography; Coronary Angiography; Coronary Di | 1973 |
Stability in urea as a measure of cardiac lactate dehydrogenase on the centrifugal analyzer.
Topics: Aspartate Aminotransferases; Autoanalysis; Creatine Kinase; Drug Stability; Electrocardiography; Eva | 1974 |
The diagnostic value of serum LDH isoenzymes and heat-stable and urea-stable LDH measurements.
Topics: Alanine Transaminase; Alkaline Phosphatase; Angina Pectoris; Clinical Enzyme Tests; Electrophoresis; | 1971 |
Transient blindness associated with renal failure.
Topics: Adult; Aged; Blindness; Body Weight; Brain Edema; Creatinine; Electroencephalography; Female; Hemogl | 1971 |
[Application of urea for differentiation of lactate dehydrogenase in myocardial infarct].
Topics: Humans; L-Lactate Dehydrogenase; Liver; Myocardial Infarction; Myocardium; Urea | 1970 |
Peritoneal dialysis for pulmonary oedema after acute myocardial infarction.
Topics: Aged; Heart Block; Humans; Male; Middle Aged; Myocardial Infarction; Peritoneal Dialysis; Potassium; | 1970 |
[Diagnosis of myocardial infarct by determination of urea stabile lactate dehydrogenase].
Topics: Aminohydrolases; Aspartate Aminotransferases; Clinical Enzyme Tests; Creatine Kinase; Electrocardiog | 1970 |
[Comparative deermination of heart-specific LDH in the serum by inactivation of urea and acrylamide electrophoresis].
Topics: Acrylamides; Electrophoresis; Enzyme Repression; Humans; Isoenzymes; L-Lactate Dehydrogenase; Liver | 1970 |
The lactic dehydrogenase isoenzymes of human serum.
Topics: Butyrates; Cholestasis; Drug Stability; Electrophoresis; Hepatitis; Hot Temperature; Humans; Hydroxy | 1970 |
[Some problems of the treatment of pulmonary edema in myocardial infarct].
Topics: Aged; Female; Furosemide; Humans; Male; Middle Aged; Myocardial Infarction; Pulmonary Edema; Silicon | 1968 |
Determination of LDH isoenzymes in serum: a urea inhibition method compared with an electrophoretic method.
Topics: Blood Chemical Analysis; Electrophoresis; Hepatitis; Humans; Isoenzymes; L-Lactate Dehydrogenase; My | 1968 |
[Diagnostic value of urea and potassium oxalate in recent myocardial infarction for the inhibition of lactate dehydrogenase and alpha-hydroxybutyrate dehydrogenase].
Topics: Adult; Aged; Enzyme Repression; Female; Humans; Hydroxybutyrate Dehydrogenase; L-Lactate Dehydrogena | 1969 |
[Inhibition of serum lactate dehydrogenase activity with urea in diagnosed cases of myocardial infarct].
Topics: Humans; L-Lactate Dehydrogenase; Myocardial Infarction; Urea | 1966 |